Maxim analyst Anthony Vendetti initiated coverage of Herbalife (HLF) with a Buy rating and $20 price target A turnaround is underway, enabling Herbalife to solidify its status as a leading provider of health and wellness products, the analyst tells investors in a research note. Maxim believes the U.S. regulatory concerns are resolved, and the resulting changes, including closer alignment of distributor compensation with sales to end users, have established a more sustainable business model. Claim 70% Off ...